Fundraising FoxAnaBios Corporation
San Diego, US · 3 known investors
Find your way into AnaBios Corporation
Each arrow is one introduction. Sign up to fill in the first one.
Ask David Q. Anderson to introduce you to Andre Ghetti
You →David · together at AnaBios Corporation →Andre
Sign up to find every way you can get introduced to AnaBios Corporation
- Your email: who you already know at AnaBios Corporation, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the AnaBios Corporation team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
AnaBios generates predictive human data for pharmaceutical drug development, using authentic human cells and tissues from healthy and diseased donors to assess drug efficacy and toxicity before clinical trials. It offers human tissue procurement and functional assay services, including gene expression, proteomic, and metabolomic profiling, to support drug discovery and preclinical safety testing.
Founders & leadership
Investors · 3
Reported raises · per SEC filings
Form D private placements$13.4M disclosed across 3 rounds · 2016–2022
▶$6.5MraisedJun 2022 · 1 investors · BiotechnologyRule 506(b)
- Melanie FanDirector
- Andre GhettiExecutive Officer
- Jack ReynoldsExecutive Officer, Director
- Peter CrowleyDirector
- Richard ErdmanDirector
- Paul E MillerExecutive Officer
- David AndersonDirector
- Offering amount
- $6.5M
- Amount sold
- $6.5M
- First sale
- May 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.1MraisedJun 2020 · 16 investors · BiotechnologyRule 506(b)
- Paul E MillerExecutive Officer
- George GoldsmithExecutive Officer
- Richard ErdmanDirector
- Peter CrowleyExecutive Officer, Director
- Jack ReynoldsExecutive Officer, Director
- Andre GhettiExecutive Officer
- Martin WatersExecutive Officer
- Offering amount
- $7M
- Amount sold
- $1.1M
- Sales commissions
- $490K
- Placement agents
- ARCADIA SECURITIES, LLC
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.8MraisedJun 2017 · 63 investors · BiotechnologyRule 506(b)
- Richard F. ErdmanDirector
- Paul MillerExecutive Officer
- Jack ReynoldsExecutive Officer, Director
- Peter CrowleyDirector
- George GoldsmithDirector
- Martin J. WatersExecutive Officer
- Andre GhettiExecutive Officer, Director
- Offering amount
- $8.4M
- Amount sold
- $5.8M
- Finders' fees
- $254.1K
- Placement agents
- CIM Securities, LLC, Brookline Group, LLC
- First sale
- May 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Companies working in the same space as AnaBios Corporation.
Non-dilutive funding · 5 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $1.7M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $1.1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $320.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $200.7K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does AnaBios Corporation do?
- AnaBios generates predictive human data for pharmaceutical drug development, using authentic human cells and tissues from healthy and diseased donors to assess drug efficacy and toxicity before clinical trials. It offers human tissue procurement and functional assay services, including gene expression, proteomic, and metabolomic profiling, to support drug discovery and preclinical safety testing.
- Who founded AnaBios Corporation?
- AnaBios Corporation was founded by Andre Ghetti.
- Who are AnaBios Corporation's investors?
- AnaBios Corporation's investors include Ampersand, Keiretsu Forum, Tech Coast Angels.
- How much funding has AnaBios Corporation raised?
- AnaBios Corporation has disclosed $13.4M raised across 3 rounds.
- Where is AnaBios Corporation headquartered?
- AnaBios Corporation is headquartered in San Diego, US.